Сравнительная антигипертензивная эффективность фиксированных комбинаций периндоприла и индапамида у пациентов с артериальной гипертензией и высоким сердечно-сосудистым риском
Explore this paper's citation graph
Summary
MBP is required in HTN high-risk patients who take indapamide / perindopril erbuminе K in order to assess the reduction in nighttime BP, independently of achieving target office BP values.
- Type
- article
- Published
- 2017-07-18
- Cited by
- 0
- References
- 0
- Access
- Open access
- OpenAlex
- https://openalex.org/W2736594931
- Semantic Scholar
- https://api.semanticscholar.org/CorpusID:79880507
Keywords
Indapamide, Perindopril, Medicine, Blood pressure, Internal medicine
References
No references recorded for this paper.
Cited by
No citing papers recorded for this paper.
Related papers
- [Clinical study of the month. Secondary prevention of cerebrovascular accident with perindopril: the PROGRESS study].
- `PROGRESS' in prevention of stroke
- The effect of treatment with low dose ACE inhibitor and/or diuretic on coronary microvasculature in stroke-prone spontaneously hypertensive rats.
- Efficacy analysis of Perindopril combined with Indapamide in primary hypertension
- Very-low-dose combination of perindopril and indapamide as a novel strategy in first-line management of hypertension.
- Persistence of the antihypertensive effect of low‐dose combination therapy in mild hypertension